Cargando…
Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis
INTRODUCTION: Ectopic pregnancy is an important health condition which affects up to 1 in 100 women. Women who present with mild symptoms and low serum human chorionic gonadotrophin (hCG) are often treated with methotrexate (MTX), but expectant management with close monitoring is a feasible alternat...
Autores principales: | Solangon, Sarah Annie, Van Wely, Madelon, Van Mello, Norah, Mol, Ben W., Ross, Jackie A., Jurkovic, Davor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407021/ https://www.ncbi.nlm.nih.gov/pubmed/37345445 http://dx.doi.org/10.1111/aogs.14617 |
Ejemplares similares
-
Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022) -
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
por: May, James, et al.
Publicado: (2018) -
β-hCG resolution times during expectant management of tubal ectopic pregnancies
por: Mavrelos, D., et al.
Publicado: (2015) -
The ESEP study: Salpingostomy versus salpingectomy for tubal ectopic pregnancy; The impact on future fertility: A randomised controlled trial
por: Mol, Femke, et al.
Publicado: (2008) -
A protocol for developing a core outcome set for ectopic pregnancy
por: Chong, Krystle Y., et al.
Publicado: (2021)